Rishabh Instruments consolidated PAT falls 18% YoY to ₹18.1 Cr on margin squeeze
PAT -17.94% YoY · revenue +8.38% · margins compressing
₹212.78 Cr
+8.38% YoY
₹18.13 Cr
-17.94% YoY
8.37%
-2.6pp YoY
₹4.69
Rishabh Instruments' consolidated PAT fell 17.9% year-on-year to ₹18.13 Cr in Q2 FY27 (from ₹22.09 Cr in Q2 FY26) even as revenue from operations grew 8.4% YoY to ₹212.78 Cr — the third straight quarter of margin compression, with net profit margin sliding to 8.52% from 9.59% in Q1 FY27 and 10.98% a year ago, and OPM (EBITDA margin) down to 15.24% from 16.80% sequentially and 17.00% YoY. Sequentially, PAT also slipped 6.4% versus Q1 FY27's ₹19.36 Cr despite revenue rising 7.3% QoQ, so the growth-without-profit pattern is not a one-quarter blip. No street consensus estimate specific to this quarter's PAT or revenue could be located (vsStreet: unknown); the only public figure found was a full-year FY27 consensus revenue estimate of roughly ₹823 Cr, which is not comparable to a single quarter's print.
Q2 FY-2027 vs prior quarters
The squeeze sits below the EBITDA line: finance costs jumped to ₹17.96 Cr from ₹10.89 Cr a year ago (+65%) and depreciation rose to ₹99.86 Cr (standalone-equivalent run-rate; consolidated ₹9.99 Cr in the quarterly table) from ₹8.68 Cr, both tracking the build-out in property, plant and equipment (consolidated gross block up to ₹346.2 Cr from ₹325.6 Cr at FY26-end). Cost of material and employee expense grew in line with revenue, so the drag is fixed-cost absorption from ongoing capex rather than input-cost inflation. Management's EEI-segment guidance (20% revenue growth, 20-22% EBITDA margin) and Alucast's targeted FY27-end EBITDA breakeven cannot be checked line-by-line since this filing discloses revenue only by geography — but the consolidated OPM of 15.24% remains well below the 20-22% EEI target, consistent with Alucast still being a sub-scale drag on the blended number as guided. Geographically, Europe — still 58% of consolidated revenue — declined 7.2% YoY to ₹124.03 Cr, offset by Asia (+30.7% to ₹60.03 Cr) and Other markets (+71.3% to ₹28.72 Cr); this is the detail behind the topline growth and it is weaker-market revenue, not Europe, doing the heavy lifting.
The stock went into the print at ₹632.1, down 9.2% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Basic consolidated EPS ₹4.69 vs ₹5.77 a year ago and ₹4.93 last quarter
EEI segment: 20% revenue growth, 20-22% EBITDA margin (maintained). US target: ₹45 Cr FY27, ₹100 Cr in 2-3 years. Solar: ₹24-25 Cr this year, ₹250-300 Cr next year. Alucast: EBITDA breakeven by end FY27, double-digit margins in 2 years.
On governance, the quarter carried a company denial of stake-sale rumours (Aug 21) and a previously flagged deviation in fund utilisation (Aug 14) that this filing does not elaborate on or resolve — neither is reflected in the P&L and both are noted here only because they occurred within the reporting window. No management press release accompanied this result in the available record, so the quarter's framing rests on the filing and notes alone: an unmodified limited-review conclusion, no exceptional items, and the ₹2/share FY26 final dividend already paid during the quarter. Standalone PAT came in at ₹13.54 Cr on revenue of ₹88.01 Cr, with the gap to consolidated (₹212.78 Cr revenue) underscoring how much of the business now sits in overseas subsidiaries (Lumel, Sifam Tinsley, Shanghai VA) rather than the parent.
W1
Whether finance cost (₹17.96 Cr this quarter, +65% YoY) and depreciation stabilise as the capex cycle behind the ₹346.2 Cr gross block matures
W2
Europe revenue — a second consecutive YoY decline there would flag demand softness in the company's largest market (58% of consolidated revenue)
W3
Progress against management's EEI (20-22% EBITDA margin) and Alucast (FY27-end EBITDA breakeven) targets, against a consolidated OPM that has now fallen to 15.24%
Clean digital filing, no exceptional items on either statement; consolidated PAT is total profit for the period (before NCI split, ₹18.127 Cr = owners ₹18.026 Cr + NCI ₹0.101 Cr), matching the convention used for the comparison-period figures supplied; consolidated segmentation is geography-only (Asia/Europe/Other) so EEI/US/Solar/Alucast business-line guidance cannot be directly verified from this filing.
EEI Momentum & Execution Under Watch—Q2 FY-2027 Preview
Rishabh Instruments reports Nov 13 with momentum on its side but margins scrutinised. Q1's 34% EEI growth and 17.3% EBITDA expansion set a high bar; Street watches for sustained execution amid rising overseas competition and fund deployment.
The Setup: EEI Carrying the Load
Rishabh Instruments enters Q2 FY-2027 riding the back of an impressive Q1 print. The company's Electrical and Electronic Instruments (EEI) segment—the growth engine—delivered 34% YoY revenue growth, far exceeding initial full-year guidance. Consolidated EBITDA expanded 17.3% YoY, with margins holding at 16.8%, while standalone India operations posted 25.6% revenue growth and a robust 22.9% EBITDA margin. The metric to watch in Q2 is whether this momentum is durable or a seasonal peak, and critically, whether margins can be defended as operational scale tests input costs and forex headwinds.
~₹200 Cr
Q1 FY27 was ₹198.3 Cr consolidated; on-plan implies steady run-rate or low-single-digit growth YoY
16–17% Consol.
Q1 posted 16.8%; expect defensible but under pressure if input costs or forex weigh
Watch for +20%+ YoY
Q1's 34% was exceptional; sustaining +20% YoY would confirm end-market strength, not just catch-up
~₹20–22 Cr
Q1 delivered ₹19.4 Cr; modest upside from better scale and lower financing costs possible
Strong vs Weak Q2: What Moves the Needle
A strong Q2 print: Revenue flat-to-modest growth (3–5% YoY) from Q1's base; EBITDA margin holds 16.5–17.2%; EEI segment confirms +20%+ growth; PAT in ₹21–23 Cr range; management reaffirms or raises full-year EBITDA growth guidance to 12–15% YoY. A weak print: Revenue contraction or flat YoY; EBITDA margin compresses below 16%; EEI growth slows to single digits; PAT disappoints below ₹19 Cr; guidance cut or guidance withdrawn citing macro/currency headwinds. The Street is watching for evidence that Q1 was sustainable, not a one-quarter pop.
On Track? Tracking Guidance & the Full Year
Rishabh's full-year FY-2027 guidance (not yet formal from prior earnings call) is estimated by consensus at ₹823 Cr revenue (+6.2% YoY FY-level growth). Q1 contributed ₹198.3 Cr (roughly 24% of the full-year run-rate). For the company to hit ₹823 Cr annualized, Q2–Q4 must collectively deliver ~₹625 Cr, or roughly ₹208 Cr per quarter. Q1's sequential base is achievable; the question is whether margin expansion (a key FY-2027 mandate) can be sustained, or if input costs and forex pressure will force a profit-growth guidance cut despite revenue meet.
Since Last Quarter: Recent Filings & Corporate Actions
1 · Stake-Sale Denial (Aug 21)
Rishabh denied reports of promoters in talks to sell a controlling stake. Promoter holding remains stable at 69.40% (Q1 FY-2027); no recent pledges flagged. Routine, but liquidity/control risk cited intra-quarter.
2 · Fund Utilization Deviation (Aug 14)
Company reported a deviation in fund deployment against its Sep-2023 ₹750 Cr IPO capital raise. Filing notes slower-than-planned capex on certain projects. Watch for colour in Q2 call: is this a timing issue or a capex reprieve? Either way, lower capex improves near-term FCF but may signal cautious mid-cycle spending.
3 · Trading Window Closure (Sep 28)
Insider-trading window closed for Q2 results announcements, standard pre-earnings protocol. No material insider trades disclosed since Q1 earnings call. Routine.
4 · Board Meeting Scheduled (Nov 13)
Board to convene on result-day to consider and approve Q2 FY-2027 unaudited standalone and consolidated results. Earnings announcement expected late morning/early afternoon IST. On schedule; no delays flagged.
Three Things to Watch on Result Day
1 · EEI momentum: Do margins hold at 16.5%+?
Q1's 34% EEI growth is a high bar. The real test is whether Q2 shows sustained 20%+ YoY growth AND EBITDA margin remains above 16.5%. Margin compression (anything below 16%) on strong revenue growth would signal input-cost or forex drag not yet reflected in guidance.
2 · FY-2027 full-year guidance: Is ₹823 Cr revenue in play?
If Q2 is flat/slightly down YoY or management lowers FY-guidance, Street will question EEI durability. Conversely, a reaffirm or raise to ₹850+ Cr would validate the execution story and likely trigger re-rating.
3 · Capex & fund deployment: When does the ₹750 Cr IPO capital deploy?
The Aug deviation filing suggests slower capex. Q2 call will clarify: is this prudence, a reprieve, or a shift in capex timing? Lower capex now could be FCF-accretive but may flag softer medium-term growth expectations if pushed out.
Rishabh Instruments enters Q2 with strong momentum but at an inflection. Q1's EEI growth of 34% and EBITDA expansion of 17.3% set a bar most Indian instrumentation peers cannot match. The Street is betting on execution, but the ask is clear: prove the growth is durable, margins are defensible, and capex deployment is on track. The Nov 13 print will either validate conviction (and likely trigger fresh upside in the target base) or expose execution risks (fund-deployment caution, margin pressure, slowing EEI) that could temper Street revisions. For a stock trading at ₹643.3 with a median analyst target of ₹630, the onus is on the company to deliver.